Rheumatoid Arthritis: Epidemiology Forecast to 2027

2019-01-17
Price :
Published : Jan-2019
No. of Pages : 46
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Rheumatoid Arthritis: Executive Summary
2.1 Related Reports
2.2 Upcoming Reports
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global and Historical Trends
3.4 Forecast Methodology
3.4.1 Sources
3.4.2 Forecast Assumptions and Methods
3.4.3 Diagnosed Incident Cases of RA
3.4.4 Diagnosed Prevalent Cases of RA
3.4.5 Diagnosed Prevalent Cases of RA by Severity
3.4.6 Total Prevalent Cases of RA
3.5 Epidemiological Forecast for Rheumatoid Arthritis (2017-2027)
3.5.1 Diagnosed Incident Cases of RA
3.5.2 Age-Specific Diagnosed Incident Cases of RA
3.5.3 Sex-Specific Diagnosed Incident Cases of RA
3.5.4 Diagnosed Prevalent Cases of RA
3.5.5 Age-Specific Diagnosed Prevalent Cases of RA
3.5.6 Sex-Specific Diagnosed Prevalent Cases of RA
3.5.7 Diagnosed Prevalent Cases of RA by Severity
3.5.8 Total Prevalent Cases of RA
3.5.9 Age-Specific Total Prevalent Cases of RA
3.5.10 Sex-Specific Total Prevalent Cases of RA
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 Limitations of Analysis
3.6.3 Strengths of Analysis
4 Appendix
4.1 Bibliography
4.2 Primary Research - KOLs Interviewed for this Report
4.3 Primary Research - Prescriber Survey
4.4 About the Authors
4.4.1 Epidemiologist
4.4.2 Reviewers
4.4.3 Global Director of Therapy Analysis and Epidemiology
4.4.4 Global Head and EVP of Healthcare Operations and Strategy
4.5 About GlobalData
4.6 Contact Us
4.7 Disclaimer

1.1 List of Tables
Table 1: Risk Factors and Comorbidities of RA
Table 2: 1987 ACR Diagnostic Criteria for RA
Table 3: High-Prescribing Physicians (Non-KOLs), Surveyed by Country, 2018

1.2 List of Figures
Figure 1: 8MM, Diagnosed Incident Cases of RA, Both Sexes, Ages ?18 Years, N, 2017 and 2027
Figure 2: 8MM, Diagnosed Prevalent Cases of RA, Both Sexes, Ages ?18 Years, N, 2017 and 2027
Figure 3: 8MM, Total Prevalent Cases of RA, Both Sexes, Ages ?18 Years, N, 2017 and 2027
Figure 4: 8MM, Age-Standardized Diagnosed Incidence of RA (Cases per 100,000 Population), Both Sexes, Ages ?18 Years, 2017
Figure 5: 8MM, Age-Standardized Diagnosed Prevalence of RA (%), Men, Ages ?18 Years, 2007 to 2027
Figure 6: 8MM, Age-Standardized Diagnosed Prevalence of RA (%), Women, Ages ?18 Years, 2007 to 2027
Figure 7: 8MM, Age-Standardized Total Prevalence of RA (%), Men, Ages ?18 Years, 2007 to 2027
Figure 8: 8MM, Age-Standardized Total Prevalence of RA (%), Women, Ages ?18 Years, 2007 to 2027
Figure 9: 8MM, Sources Used to Forecast the Diagnosed Incident Cases of RA
Figure 10: 8MM, Sources Used to Forecast the Diagnosed Prevalent Cases of RA
Figure 11: 8MM, Sources Used to Forecast the Total Prevalent Cases of RA
Figure 12: 8MM, Diagnosed Incident Cases of RA, Both Sexes, Ages ?18 Years, N, 2017
Figure 13: 8MM, Age-Specific Diagnosed Incident Cases of RA, Both Sexes, Ages ?18 Years, N, 2017
Figure 14: 8MM, Sex-Specific Diagnosed Incident Cases of RA, Ages ?18 Years, N, 2017
Figure 15: 8MM, Diagnosed Prevalent Cases of RA, Both Sexes, Ages ?18 Years, N, 2017
Figure 16: 8MM, Age-Specific Diagnosed Prevalent Cases of RA, Both Sexes, Ages ?18 Years, N, 2017
Figure 17: 8MM, Sex-Specific Diagnosed Prevalent Cases of RA, Ages ?18 Years, N, 2017
Figure 18: 8MM, Diagnosed Prevalent Cases of RA By Severity, Both Sexes, Ages ?18 Years, N, 2017
Figure 19: 8MM, Total Prevalent Cases of RA, Both Sexes, Ages ?18 Years, N, 2017
Figure 20: 8MM, Age-Specific Total Prevalent Cases of RA, Both Sexes, Ages ?18 Years, N, 2017
Figure 21: 8MM, Sex-Specific Total Prevalent Cases of RA, Ages ?18 Years, N, 2017
Filed in: Pharmaceutical
Publisher : GlobalData